Drug intelligence / Profile preview

Biminne

Development stage
Unknown
Lead developer
G & W Aust
Administration
Oral
01

Overview

Biminne is a multi-herb formulation developed by G & W Australia for the symptomatic relief of allergic diseases, particularly allergic rhinitis (hay fever) and sinusitis. The formulation consists of extracts from eleven traditional Chinese herbs, including *Scutellaria baicalensis*, *Astragalus membranaceus*, and *Ginkgo biloba*. It is administered orally, typically in capsule form, and functions by improving immune regulation, reducing allergy-related antibodies (specifically total serum IgE), and controlling inflammation. Clinical trials conducted by researchers at the University of Sydney have demonstrated its efficacy in treating perennial allergic rhinitis, with evidence suggesting that the therapeutic benefits can persist for up to one year following the completion of treatment.

Brand names
Biminne
Other names
Bimin FormulaBinmin Formula
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)IL8 (C-X-C Motif Chemokine Ligand 8)CXCL2 (C-X-C motif chemokine ligand 2)CCL20 (C-C motif chemokine ligand 20)IL1B (Interleukin-1 beta)

Beyond the preview

Go deeper on Biminne.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biminne.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call